Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis

RT @dimitar_dr: well done- - #ctc are gaining more and more importance in the accurate #diagnosis of #breastcancer . our portfolio compan…

well done- - #ctc are gaining more and more importance in the accurate #diagnosis of #breastcancer . our portfolio company NM Genomix offers an excellent opportunity for such #liquidbiopsy done already in almost 1000 patients in Bulgaria https://t.co/jMm

#AGL @Parsortix 'Conclusion: The results of this meta-analysis confirmed that CTCs were an important component of noninvasive methods of confirming BC...' '..and early diagnosis, with better sensitivity and specificity.'

New research: Circulating tumor cells in peripheral blood as a diagnostic biomarker of breast cancer: A meta-analysis: Purpose Studies have reported that breast cancer (BC) patients’ circulating tumor cells (CTCs) have varying results for… https://t.co/Ho